Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kura Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.054 Please stand by, your program is about to begin. 00:00:02.054 -- 00:00:06.921 If you need assistance during your conference today, please press star zero. 00:00:06.921 -- 00:00:11.949 Good day, everyone, and welcome to today's first quarter 2025 Cura Oncology Financial 00:00:11.949 -- 00:00:17.477 Results Conference Call. At this time, all participants are in a listen-only mode. 00:00:17.477 -- 00:00:20.762 Later, you will have the opportunity to ask questions during the question and answer 00:00:20.762 -- 00:00:25.209 session. You may register to ask a question at any time by pressing star one on your 00:00:25.209 -- 00:00:30.372 telephone keypad. You may withdraw yourself from the queue by pressing star two. 00:00:30.372 -- 00:00:33.737 Please note this call may be recorded and I will be standing by if you should need any 00:00:33.737 -- 00:00:35.720 assistance. 00:00:35.720 -- 00:00:39.466 It is now my pleasure to turn the conference over to Apoorva Chollui. 00:00:39.466 -- 00:00:41.826 Please go ahead. 00:00:42.570 -- 00:00:47.738 Thank you, operator. Good afternoon and welcome to Cura Oncology's first quarter 2025 00:00:47.738 -- 00:00:50.522 conference call. Joining me on the call are Dr. 00:00:50.522 -- 00:00:54.228 Troy Wilson, President and Chief Executive Officer, Dr. 00:00:54.228 -- 00:00:59.482 Molly Leone, Chief Medical Officer, Brian Powell, Chief Commercial Officer, 00:00:59.482 -- 00:01:03.428 and Tom Doyle, Senior Vice President of Finance and Accounting. 00:01:03.428 -- 00:01:07.755 Before I turn the call over to Dr. Wilson, I'd like to remind you that today's call will 00:01:07.755 -- 00:01:11.361 include forward-looking statements based on current expectations. 00:01:11.361 -- 00:01:16.149 Such statements repres...